0001209191-23-005712.txt : 20230131
0001209191-23-005712.hdr.sgml : 20230131
20230131164211
ACCESSION NUMBER: 0001209191-23-005712
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230127
FILED AS OF DATE: 20230131
DATE AS OF CHANGE: 20230131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lee Yuchun
CENTRAL INDEX KEY: 0001334365
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 23573067
MAIL ADDRESS:
STREET 1: 170 TRACER LA.
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-27
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001334365
Lee Yuchun
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2023-01-27
4
M
0
1429
72.14
A
3304
D
Common Stock
2023-01-27
4
S
0
379
321.31
D
2925
D
Common Stock
2023-01-27
4
S
0
970
322.20
D
1955
D
Common Stock
2023-01-27
4
S
0
80
323.33
D
1875
D
Stock Option (Right to Buy)
72.14
2023-01-27
4
M
0
1429
0.00
D
2024-05-31
Common Stock
1429
0
D
Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $321.31 (range $320.62 to $321.59).
Open market sales reported on this line occurred at a weighted average price of $322.20 (range $321.75 to $322.74).
Fully vested.
/s/ Christiana Stevenson, Attorney-in-Fact
2023-01-31